Clinical Trial Update: A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic Recurrence Following Surgery for Crohn's Disease. [Phase 3]

View source ↗

Summary

This is a completed Phase 3 randomized trial evaluating VSL#3 to prevent endoscopic recurrence after Crohn's disease surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease

Drugs mentioned

• VSL#3

Snippet

Sponsor: University of Alberta | Conditions: Crohn's Disease, Inflammatory Bowel Disease | Phase 3 | Status: COMPLETED